---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-001148"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-02-14T23:59:59+00:00"
generated_at: "2026-06-27T08:38:40.314708+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Mednax closes $1.1B financing, redeems $1B 6.25% notes due 2027

## Summary
- Issued $400M 5.375% senior notes due 2030, new $450M revolver and $250M term loan.
- Used proceeds plus cash to redeem all $1B of 6.25% senior notes due 2027.
- Outstanding debt reduced to ~$750M; net proceeds from notes ~$394.5M after discounts.
- Credit agreement amended with SOFR-based pricing, matures Feb 2027; lower margins.
- Notes callable at make-whole before Feb 2025, then step-down redemption prices.

## SEC filing metadata
- accession: 0000950170-22-001148
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-02-14T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000095017022001148/0000950170-22-001148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000095017022001148/md-20220211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-001148
- JSON: https://secwatch.observer/filing/0000950170-22-001148.json
- Plain text: https://secwatch.observer/filing/0000950170-22-001148.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.